Jack Nathan Medical (TSE:JNH) has released an update.
Jack Nathan Health reported a robust 21% increase in revenue for Q2 of fiscal 2025, driven by the optimization of clinic operations and a strategic focus on operational efficiency. The company’s clinic operations, which now constitute a larger share of total revenues, reflect their commitment to improving service delivery and reaching full capacity at their facilities.
For further insights into TSE:JNH stock, check out TipRanks’ Stock Analysis page.
